HCHyung-Lok Chung

Hyung-Lok Chung

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Hyung-Lok Chung has a total of 122 co-authors. Here are the top co-authors by number of shared publications:

  • Hugo Jozef Bellen

    Baylor College of Medicine

    4 shared publications
  • Shinya Yamamoto

    Department of Molecular and Human Genetics, Baylor College of Medicine , Houston, TX 77030

    3 shared publications
  • Ye-Jin Park

    Department of Molecular and Human Genetics, Jan and Dan Duncan Neurological Institute, Baylor College of Medicine, Houston, USA

    3 shared publications
  • Ye-Jin Park

    Affiliations Department of Molecular and Human Genetics, Baylor College of Medicine (BCM), Houston, Texas, United States of America, Jan and Dan Duncan Neurological Research Institute (NRI), Texas Children’s Hospital (TCH), Houston, Texas, United States of America, Development, Disease Models & Therapeutics Graduate Program, BCM, Houston, Texas, United States of America, Huffington Center on Aging, BCM, Houston, Texas, United States of America

    3 shared publications
  • Zhongyuan Zuo

    Department of Molecular and Human Genetics, Jan and Dan Duncan Neurological Institute, Baylor College of Medicine, Houston, USA

    3 shared publications
  • Hyun Kyoung Lee

    Jan and Dan Duncan Neurological Research Institute, Texas Children's Hospital, Houston, Texas, USA 77030; Department of Pediatrics, Baylor College of Medicine, Houston, Texas, USA 77030; Department of Neuroscience, Baylor College of Medicine, Houston, Texas USA 77030

    2 shared publications

Latest Publications

  • Identification of novel CDK19 variants and Drosophila-based in vivo functional evidence supporting pathogenicity in neurodevelopmental disorders

    by Hyun Yong Koh, Ranjan K. Sahu, Sung Dae Kim, Tomomi Tanaka, Karampal S. Grewal, Jenny Zhe Liao, Yoon-Kyung Shim, Ria Garg, Ilona Krey, Viktoria Bothe, et al.

  • Open Access

    Hippo signaling regulates cuticle pigmentation and dopamine metabolism in Drosophila

    by Shelley B. Gibson, Samantha L. Deal, Ye-Jin Park, Bo Sun, Yanyan Qi, Jung-Wan Mok, Hyung-Lok Chung, Hongjie Li, Shinya Yamamoto

    Pigmentation plays multiple important roles in development, physiology and evolution. Melanization of the insect cuticle requires dopamine as a precursor of melanin and involves key enzymes in dopamine biosynthesis including Tyrosine hydroxylase (TH) and Dopa decarboxylase (Ddc). Some studies have hinted that disruption of the evolutionarily conserved Hippo signaling pathway, which has been primarily studied in the context of tissue growth, may lead to changes in cuticle pigmentation in the fruit fly Drosophila melanogaster . However, to our knowledge, there have not been any systematic investigations into their potential mechanistic links. In this study, we identified that all genes that comprise the canonical Hippo signaling pathway [ hippo ( hpo ), salvador ( sav ), mats , warts ( wts ), yorkie ( yki ) and scalloped ( sd )] are involved in cuticle pigmentation in the fly notum based on tissue-specific gene knock-down/out experiments and epistatic analysis. Despite the notable divergence of pigmentation mechanisms between invertebrates and vertebrates, these phenotypes can often be rescued by the human orthologs of corresponding fly genes. While we find that manipulation of Hippo signaling in dopaminergic neurons does not affect global dopamine levels in the fly brain, developmental inhibition of this pathway can increase dopamine levels in the fly head, indicating that the mechanism by which dopamine levels are regulated in the nervous system is distinct from that in epithelial cells. Through single nuclei RNA sequencing of the developing fly nota and subsequent functional studies of differentially expressed genes that are altered upon inhibition of Hippo signaling, we found many genes that contribute to cuticle pigmentation downstream of Hippo signaling. We conclude that regulation of cuticle pigmentation by canonical Hippo signaling acts through multiple downstream genes rather than directly through TH and Ddc. We also propose that the Drosophila melanogaster cuticle may serve as a useful platform to identify previously uncharacterized mediators of Hippo signaling as well as an in vivo experimental system to test the functionality of rare genetic variants found in human Hippo signaling orthologs associated with a variety of diseases.

  • Open Access

    DDX23 gain-of-function linked to autism spectrum disorder with intellectual disability, motor delay and seizure

    by Ranjan K. Sahu, Lynne M. Bird, Alexa R. Geltzeiler, Pradeep Vasudevan, Marcelo Vargas, Beau Crabb, Jessica Ruedy, Wendy K. Chung, Hyunglok Chung

  • Open Access

    Genetic analysis of the X-linked adrenoleukodystrophy gene ABCD1 in Drosophila uncovers a conserved phenotype

    by Joshua Manor, Sharayu V. Jangam, Hyung-Lok Chung, Pranjali Bhagwat, Jonathan C. Andrews, Hillary Chester, Shu Kondo, Saurabh Srivastav, Juan Botas, Ann B. Moser, et al.

    X-linked adrenoleukodystrophy (X-ALD) is a progressive neurodegenerative disorder caused by a loss-of-function (LOF) mutation in the ATP-binding cassette subfamily D member 1 (ABCD1) gene, leading to the accumulation of very long-chain fatty acids (VLCFAs). This disorder exhibits striking heterogeneity; some male patients develop an early childhood neuroinflammatory demyelination disorder, while other patients, including adult males and most affected female carriers, experience a chronic progressive myelopathy. Adrenocortical failure is observed in almost all male patients, with the age of onset varying, sometimes being the first diagnostic finding. The gene underlying this spectrum of disease encodes an ATP-binding cassette (ABC) transporter that localizes to peroxisomes and facilitates VLCFA transport. X-ALD is considered a single peroxisomal component defect and does not play a direct role in peroxisome assembly. Drosophila models of other peroxisomal genes have provided mechanistic insight into some of the neurodegenerative mechanisms with reduced lifespan, retinal degeneration, and VLCFA accumulation. Here, we perform a genetic analysis of the fly ortholog Abcd1 (CG2316). Knockdown or knockout of Abcd1 leads to salivary gland defects, reduced peroxisomal abundance, and VLCFA accumulation. Our null model further highlights locomotor impairment and lifespan abnormalities. Flies overexpressing the human cDNA for ABCD1, but not the fly Abcd1, display a wing crumpling phenotype characteristic of the Pex2 loss-of-function. Taken together, our data establishes the loss-of-function phenotypes for Abcd1 in Drosophila, which resemble X-ALD pathology, and suggests that overexpression of human ABCD1 may act as an inhibitor of peroxisomal biogenesis in flies. This fly model provides valuable insight into disease mechanisms and offers a versatile platform to model cerebral ALD, functionally resolve ABCD1 variants by their capacity to mitigate the biogenesis defect, assess the restorative potential of candidate small molecules, and enable discovery for this important disease.

  • Open Access

    Loss-of-function variants in MARK2 cause neurodevelopmental disorder

    by Yunseon Yang, Yoon-Kyung Shim, Noriko Miyake, Sanami Takada, Sebastian Silva, Alexander Peters-Foitzick, Abha R. Gupta, Emily Neuhaus, Catherine Bradley, Cora Taylor, et al.


  • Open Access

    ASAH2 deficiency affects sphingolipid homeostasis and neuromotor control, causing a progressive neurological disorder

    by Marcello Scala, Ranjan K. Sahu, Mariasavina Severino, Monica Traverso, Michele Iacomino, Marina Pedemonte, Filippo Santorelli, Stefano Tozza, Federico Zara, Chiara Fiorillo, et al.


  • Open Access

    Hippo signaling regulates cuticle pigmentation and dopamine metabolism in Drosophila

    by Shelley B Gibson, Samantha L Deal, Ye-Jin Park, Bo Sun, Yanyan Qi, Jung-Wan Mok, Hyung-Lok Chung, Hongjie Li, Shinya Yamamoto

    Pigmentation plays multiple important roles in development, physiology and evolution. Melanization of the insect cuticle requires dopamine as a precursor of melanin and involves key enzymes in dopamine biosynthesis including Tyrosine hydroxylase (TH) and Dopa decarboxylase (Ddc). Some studies have hinted that disruption of the evolutionarily conserved Hippo signaling pathway, which has been primarily studied in the context of tissue growth, may lead to changes in cuticle pigmentation in the fruit fly Drosophila melanogaster . However, there have not been any systematic investigations into their potential mechanistic links. In this study, we identified that all genes that comprise the canonical Hippo signaling pathway [ hippo ( hpo ), salvador ( sav ), mats , warts ( wts ), yorkie ( yki ) and scalloped ( sd )] are involved in cuticle pigmentation in the fly notum based on tissue-specific gene knock-down/out experiments and epistatic analysis. Despite the notable divergence of pigmentation mechanisms between invertebrates and vertebrates, these phenotypes can often be rescued by the human orthologs of corresponding fly genes. While we find that manipulation of Hippo signaling in dopaminergic neurons does not affect global dopamine levels in the fly brain, developmental inhibition of this pathway can increase dopamine levels in the fly head, indicating that the mechanism by which dopamine levels are regulated in the nervous system is distinct from that in epithelial cells. Through single nuclei RNA sequencing of the developing fly nota and subsequent functional studies of differentially expressed genes that are altered upon inhibition of Hippo signaling, we found four genes [ ciboulot ( cib ), transaldolase ( taldo ) , yellow ( y ) and Insulin-like receptor ( InR )] that contribute to cuticle pigmentation downstream of wts . Finally, we provide multiple pieces of evidence that indicate that the function of Hippo signaling in cuticle pigmentation and tissue growth can be genetically uncoupled and also identify beaten path Vc ( beat-Vc ) as a novel tissue growth regulator that acts downstream of wts but is not required for cuticle pigmentation. We conclude that regulation of cuticle pigmentation by canonical Hippo signaling acts through multiple downstream genes rather than directly through TH and Ddc. We also propose that the Drosophila melanogaster cuticle may serve as a useful platform to identify previously uncharacterized mediators of Hippo signaling as well as an in vivo experimental system to test the functionality of rare genetic variants found in human Hippo signaling orthologs associated with a variety of diseases.


  • Open Access

    Cdk8/CDK19 promotes mitochondrial fission through Drp1 phosphorylation and can phenotypically suppress pink1 deficiency in Drosophila

    by Jenny Zhe Liao, Hyung-Lok Chung, Claire Shih, Kenneth Kin Lam Wong, Debdeep Dutta, Zelha Nil, Catherine Grace Burns, Oguz Kanca, Ye-Jin Park, Zhongyuan Zuo, et al.

    Cdk8 in Drosophila is the orthologue of vertebrate CDK8 and CDK19. These proteins have been shown to modulate transcriptional control by RNA polymerase II. We found that neuronal loss of Cdk8 severely reduces fly lifespan and causes bang sensitivity. Remarkably, these defects can be rescued by expression of human CDK19, found in the cytoplasm of neurons, suggesting a non-nuclear function of CDK19/Cdk8. Here we show that Cdk8 plays a critical role in the cytoplasm, with its loss causing elongated mitochondria in both muscles and neurons. We find that endogenous GFP-tagged Cdk8 can be found in both the cytoplasm and nucleus. We show that Cdk8 promotes the phosphorylation of Drp1 at S616, a protein required for mitochondrial fission. Interestingly, Pink1, a mitochondrial kinase implicated in Parkinson’s disease, also phosphorylates Drp1 at the same residue. Indeed, overexpression of Cdk8 significantly suppresses the phenotypes observed in flies with low levels of Pink1, including elevated levels of ROS, mitochondrial dysmorphology, and behavioral defects. In summary, we propose that Pink1 and Cdk8 perform similar functions to promote Drp1-mediated fission.


  • Open Access

    Exploiting fly models to investigate rare human neurological disorders

    by Tomomi Tanaka, Hyung-Lok Chung

    Rare neurological diseases, while individually are rare, collectively impact millions globally, leading to diverse and often severe neurological symptoms. Often attributed to genetic mutations that disrupt protein function or structure, understanding their genetic basis is crucial for accurate diagnosis and targeted therapies. To investigate the underlying pathogenesis of these conditions, researchers often use non-mammalian model organisms, such as Drosophila (fruit flies), which is valued for their genetic manipulability, cost-efficiency, and preservation of genes and biological functions across evolutionary time. Genetic tools available in Drosophila , including CRISPR-Cas9, offer a means to manipulate gene expression, allowing for a deep exploration of the genetic underpinnings of rare neurological diseases. Drosophila boasts a versatile genetic toolkit, rapid generation turnover, and ease of large-scale experimentation, making it an invaluable resource for identifying potential drug candidates. Researchers can expose flies carrying disease-associated mutations to various compounds, rapidly pinpointing promising therapeutic agents for further investigation in mammalian models and, ultimately, clinical trials. In this comprehensive review, we explore rare neurological diseases where fly research has significantly contributed to our understanding of their genetic basis, pathophysiology, and potential therapeutic implications. We discuss rare diseases associated with both neuron-expressed and glial-expressed genes. Specific cases include mutations in CDK19 resulting in epilepsy and developmental delay, mutations in TIAM1 leading to a neurodevelopmental disorder with seizures and language delay, and mutations in IRF2BPL causing seizures, a neurodevelopmental disorder with regression, loss of speech, and abnormal movements. And we explore mutations in EMC1 related to cerebellar atrophy, visual impairment, psychomotor retardation, and gain-of-function mutations in ACOX1 causing Mitchell syndrome. Loss-of-function mutations in ACOX1 result in ACOX1 deficiency, characterized by very-long-chain fatty acid accumulation and glial degeneration. Notably, this review highlights how modeling these diseases in Drosophila has provided valuable insights into their pathophysiology, offering a platform for the rapid identification of potential therapeutic interventions. Rare neurological diseases involve a wide range of expression systems, and sometimes common phenotypes can be found among different genes that cause abnormalities in neurons or glia. Furthermore, mutations within the same gene may result in varying functional outcomes, such as complete loss of function, partial loss of function, or gain-of-function mutations. The phenotypes observed in patients can differ significantly, underscoring the complexity of these conditions. In conclusion, Drosophila represents an indispensable and cost-effective tool for investigating rare neurological diseases. By facilitating the modeling of these conditions, Drosophila contributes to a deeper understanding of their genetic basis, pathophysiology, and potential therapies. This approach accelerates the discovery of promising drug candidates, ultimately benefiting patients affected by these complex and understudied diseases.